Prospective Study of UDP-gluconoryltransferase (UGT) 2B17 Genotype as a Predictive Marker of Exemestane Pharmacokinetics and Pharmacodynamics in Asian Women With Hormone Receptor-positive Advanced Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Exemestane (Primary)
- Indications Breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 02 Jun 2017 Results (n=64) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 21 Jun 2016 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 21 Jun 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.